Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Journal:

The New England Journal of Medicine

Published:

2025-06-02

DOI:

10.1056/nejmoa2503701

Affiliations:

29

Authors:

27

Go to article

Institutions	Authors	Share
AstraZeneca Gaithersburg, MD, United States of America (USA)	3.000000	0.11
Universidad Mayor, Chile	1.000000	0.04
Churchill Hospital, United Kingdom (UK)	1.000000	0.04
Maria Sklodowska-Curie National Research Institute of Oncology, Poland	1.000000	0.04
Hospital of the University of Montreal (CHUM), Canada	1.000000	0.04
AstraZeneca France, France	1.000000	0.04
Novosibirsk Regional Clinical Oncology Dispensary, Russia	1.000000	0.04
UCLA Health, United States of America (USA)	1.000000	0.04
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	1.000000	0.04
Weill Cornell Medicine, United States of America (USA)	1.000000	0.04
Yonsei University, South Korea	1.000000	0.04
Hospital Universitario Marqués de Valdecilla (HUMV), Spain	1.000000	0.04
Ataturk University, Turkey	1.000000	0.04
Fundacion Favaloro Hospital Universitario, Argentina	1.000000	0.04
Osaka International Cancer Institute, Japan	1.000000	0.04
Johannes Gutenberg University Mainz (JGU), Germany	1.000000	0.04
Liga Norte Riograndense Contra o Câncer, Brazil	1.000000	0.04
University Hospitals Leuven (UZ Leuven), Belgium	1.000000	0.04
National Institute of Neoplastic Diseases (INEN), Peru	1.000000	0.04
University Cancer Center Hamburg (UCCH), UHH, Germany	1.000000	0.04
University Cancer Center Frankfurt-Marburg (UCT Frankfurt-Marburg), Germany	1.000000	0.04
National Cancer Center Hospital East, Japan	1.000000	0.04
Aichi Cancer Center Hospital, Japan	1.000000	0.04
Seoul National University Hospital (SNUH), South Korea	1.000000	0.04
Vall d'Hebron University Hospital (HUVH), ICS, Spain	0.333333	0.01
IOB Institute of Oncology, Spain	0.333333	0.01
University of Vic - Central University of Catalonia (UVic-UCC), Spain	0.333333	0.01

Interested in Oncology and Carcinogenesis?